Solutions

Enabling an optimal cancer therapy management

Our solutions provide clinicians with advanced molecular insights for precise cancer monitoring and therapy optimization.

Personalized Monitoring Platform

By focusing on individual cancer specific markers, Oncobit™ PM “Personalized Monitoring” represents a radically simplified but therefore highly cost- and time efficient cancer monitoring tool for a data-driven and optimal therapy management.

Unlike traditional PCR approaches, digital PCR is a parallelization of PCR that allows sensitive and quantitative detection of cancer markers. Our assays run on existing digital PCR infrastructure and can be easily implemented.

CE-marked under IVDR

Cost and time-efficient

Sensitive

Scalable

Clinically validated

Data-driven

Oncobit™ PM is a platform technology that is easily scalable to any cancer characterized by
hotspot mutations. With an initial focus on melanoma, our portfolio includes assays for the quantification of five critical melanoma markers.

Place an order with Kempf und Pfaltz in Switzerland, or contact info@oncobit.com. Instructions for use here.

Technical specifications
Specimen type	Plasma
Machine compatibility	Bio-Rad QX200™/QX600™
Turnaround time	<24h
Storage	-20°C
Regulatory status	CE-IVDR*

*Not for use in diagnostic procedures in other regions.

V600D	c.1799_1800. delinsAT
V600E	c.1799T>A
V600E2	c.1799_1800. delinsAA
V600K	c.1798_1799. delinsAA
V600R	c.1798_1799. delinsAG

Q61K	c.181C>A
Q61L	c.182A>T
Q61R	c.182A>G

Q209L	c.626A>T
Q209P	c.626A>C

Q209L

c.626A>T

R625C	c.1873C>T
R625H	c.1874G>A